• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A case of nivolumab-induced scleroderma-like syndrome successfully treated with intravenous immunoglobulin.

作者信息

DeMaio Alexa, Hashemi Kimberly B, Avery Alexandria, Metcalf John S, Winterfield Laura S

机构信息

Medical University of South Carolina, School of Medicine, Charleston, South Carolina.

Department of Dermatology, Medical University of South Carolina, Charleston, South Carolina.

出版信息

JAAD Case Rep. 2022 Jun 22;31:76-79. doi: 10.1016/j.jdcr.2022.06.007. eCollection 2023 Jan.

DOI:10.1016/j.jdcr.2022.06.007
PMID:36545488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9761324/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743a/9761324/58609e187f11/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743a/9761324/9312a3f0ac61/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743a/9761324/d01ab736c709/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743a/9761324/58609e187f11/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743a/9761324/9312a3f0ac61/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743a/9761324/d01ab736c709/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/743a/9761324/58609e187f11/gr3.jpg

相似文献

1
A case of nivolumab-induced scleroderma-like syndrome successfully treated with intravenous immunoglobulin.1例由纳武单抗引起的硬皮病样综合征经静脉注射免疫球蛋白成功治疗。
JAAD Case Rep. 2022 Jun 22;31:76-79. doi: 10.1016/j.jdcr.2022.06.007. eCollection 2023 Jan.
2
Severe immune thrombocytopenia induced by nivolumab in a patient with metastatic renal cell carcinoma.纳武单抗诱发的转移性肾细胞癌患者严重免疫性血小板减少症
Urol Case Rep. 2020 Jan 28;32:101128. doi: 10.1016/j.eucr.2020.101128. eCollection 2020 Sep.
3
Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy.接受免疫检查点抑制剂治疗的黑色素瘤患者的血小板减少症。
J Immunother Cancer. 2017 Feb 21;5:8. doi: 10.1186/s40425-017-0210-0. eCollection 2017.
4
Ramsay-Hunt syndrome and subsequent sensory neuropathy as potential immune-related adverse events of nivolumab: a case report.拉姆齐-亨特 综合征及随后发生的感觉神经病：纳武利尤单抗潜在免疫相关不良反应的病例报告。
BMC Cancer. 2019 Dec 16;19(1):1220. doi: 10.1186/s12885-019-6444-0.
5
Intravenous immunoglobulin-induced severe vesicular eczematous eruption successfully treated with narrow band-ultraviolet B therapy.
Photodermatol Photoimmunol Photomed. 2021 Sep;37(5):371-373. doi: 10.1111/phpp.12666. Epub 2021 Feb 19.
6
Immune-related adverse events correlate with improved survival in patients with advanced mucosal melanoma treated with nivolumab: A single-center retrospective study in Japan.免疫相关不良反应与纳武利尤单抗治疗晚期黏膜黑色素瘤患者的生存改善相关：日本单中心回顾性研究。
J Dermatol. 2020 Apr;47(4):356-362. doi: 10.1111/1346-8138.15246. Epub 2020 Jan 26.
7
Myocarditis and myasthenia gravis by combined nivolumab and ipilimumab immunotherapy for renal cell carcinoma: A case report of successful management.纳武单抗和伊匹单抗联合免疫疗法治疗肾细胞癌并发心肌炎和重症肌无力：成功治疗的病例报告
Urol Case Rep. 2020 Nov 28;34:101508. doi: 10.1016/j.eucr.2020.101508. eCollection 2021 Jan.
8
Anti-transcriptional intermediary factor 1-γ antibody-positive dermatomyositis induced by nivolumab for lung adenocarcinoma: A case report.纳武单抗诱导的抗转录中介因子1-γ抗体阳性皮肌炎用于肺腺癌：一例报告
Invest New Drugs. 2021 Feb;39(1):251-255. doi: 10.1007/s10637-020-00974-7. Epub 2020 Jul 10.
9
Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab.纳武利尤单抗治疗晚期非小细胞肺癌患者的免疫相关不良反应与临床获益的关联。
Oncologist. 2018 Nov;23(11):1358-1365. doi: 10.1634/theoncologist.2017-0384. Epub 2018 Jun 22.
10
Risk of scleroderma according to the type of immune checkpoint inhibitors.根据免疫检查点抑制剂的类型，发生硬皮病的风险。
Autoimmun Rev. 2020 Aug;19(8):102596. doi: 10.1016/j.autrev.2020.102596. Epub 2020 Jun 12.

引用本文的文献

1
Immune Checkpoint Inhibitor-Related Dysautonomia in Merkel Cell Carcinoma: A Case Report.默克尔细胞癌中与免疫检查点抑制剂相关的自主神经功能障碍：一例报告
Cancer Rep (Hoboken). 2025 Jul;8(7):e70274. doi: 10.1002/cnr2.70274.
2
Uncommon Adverse Events of Immune Checkpoint Inhibitors in Small Cell Lung Cancer: A Systematic Review of Case Reports.小细胞肺癌中免疫检查点抑制剂的罕见不良事件：病例报告的系统评价
Cancers (Basel). 2024 May 16;16(10):1896. doi: 10.3390/cancers16101896.
3
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases.

本文引用的文献

1
Generalized morphoea in the setting of combined immune checkpoint inhibitor therapy for metastatic melanoma: A case report.联合免疫检查点抑制剂治疗转移性黑色素瘤时出现的泛发性硬斑病：病例报告。
Medicine (Baltimore). 2021 Apr 23;100(16):e25513. doi: 10.1097/MD.0000000000025513.
2
Treatment of recalcitrant generalized morphea with mycophenolate mofetil and intravenous immunoglobulin.
Dermatol Ther. 2018 Sep;31(5):e12674. doi: 10.1111/dth.12674. Epub 2018 Aug 22.
3
Scleroderma-like syndrome associated with nivolumab treatment in malignant melanoma.与纳武单抗治疗恶性黑色素瘤相关的硬皮病样综合征。
生物制剂在治疗免疫检查点抑制剂相关皮肤免疫相关不良事件中的应用：病例报告综述。
Am J Clin Dermatol. 2024 Jul;25(4):595-607. doi: 10.1007/s40257-024-00866-z. Epub 2024 May 20.
4
Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database.免疫检查点抑制剂与硬皮病：来自欧洲药物警戒数据库的数据
Drugs Real World Outcomes. 2024 Mar;11(1):33-41. doi: 10.1007/s40801-023-00399-7. Epub 2023 Oct 31.
J Dermatol. 2019 Jan;46(1):e43-e44. doi: 10.1111/1346-8138.14492. Epub 2018 Jun 4.
4
Scleroderma-like skin changes induced by checkpoint inhibitor therapy.检查点抑制剂疗法诱发的硬皮病样皮肤改变
J Cutan Pathol. 2018 Aug;45(8):615-618. doi: 10.1111/cup.13273. Epub 2018 Jun 12.
5
Dermatologic Reactions to Immune Checkpoint Inhibitors : Skin Toxicities and Immunotherapy.免疫检查点抑制剂的皮肤不良反应：皮肤毒性与免疫治疗
Am J Clin Dermatol. 2018 Jun;19(3):345-361. doi: 10.1007/s40257-017-0336-3.
6
Paraneoplastic Scleroderma: Are There Any Clues?副肿瘤性硬皮病：有什么线索吗？
Acta Dermatovenerol Croat. 2016 Apr;24(1):78-80.
7
Intravenous immunoglobulin may be an effective therapy for refractory, active diffuse cutaneous systemic sclerosis.静脉注射免疫球蛋白可能是难治性、活动性弥漫性皮肤系统性硬化症的一种有效治疗方法。
J Rheumatol. 2015 Feb;42(2):236-42. doi: 10.3899/jrheum.140833. Epub 2014 Nov 29.
8
Skin score decrease in systemic sclerosis patients treated with intravenous immunoglobulin--a preliminary report.
Clin Rheumatol. 2000;19(3):207-11. doi: 10.1007/s100670050158.
9
Disabling morphoea of childhood-beneficial effect of intravenous immunoglobulin therapy.儿童致残性硬斑病——静脉注射免疫球蛋白治疗的有益效果
Clin Exp Dermatol. 1998 Nov;23(6):292-3. doi: 10.1046/j.1365-2230.1998.00378.x.